Balyasny Asset Management LLC Legend Biotech Corp Transaction History
Balyasny Asset Management LLC
- $58 Billion
- Q3 2024
A detailed history of Balyasny Asset Management LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Balyasny Asset Management LLC holds 681,174 shares of LEGN stock, worth $25.5 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
681,174
Previous 451,965
50.71%
Holding current value
$25.5 Million
Previous $20 Million
65.82%
% of portfolio
0.06%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding LEGN
# of Institutions
226Shares Held
74.5MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$418 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$281 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$248 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$214 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$189 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.27B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...